Perceptions of politicization and HPV vaccine policy support |
| |
| Institution: | 1. Department of Public Health Sciences, The University of Chicago, Chicago, IL, USA;2. Government Department, Wesleyan University, Middletown, CT, USA;3. Hubbard School of Journalism and Mass Communication, University of Minnesota, Minneapolis, MN, USA;4. Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, USA;1. Berry Technology Solutions, Inc., Peachtree City, GA, United States;2. IHRC, Inc., Atlanta, GA, United States;3. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA, United States;4. Communicable Disease Program, Chicago Department of Public Health, Chicago, IL, United States;5. Division of Immunization, Michigan Department of Health & Human Services, Lansing, MI, United States;6. Infectious Disease Prevention and Health Services Bureau, Prevention and Health Promotion Administration, Maryland Department of Health, Baltimore, MD, United States;7. Immunization Services Division, NCIRD, CDC and Adult Immunization Unit, New York City Department of Health and Mental Hygiene, New York, NY, United States;8. Public Health Division, Oregon Health Authority, Portland, OR, United States;9. San Antonio Metropolitan Health District, San Antonio, TX, United States;10. Cherokee Nation Assurance, Atlanta, GA, United States;11. Immunization Services Division, NCIRD, CDC, Atlanta, GA, United States;2. Emory Vaccine Center, Influenza Pathogenesis & Immunology Research, Emory University School of Medicine, United States;3. National Center for Immunization and Respiratory Diseases, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, United States;4. Emory University School of Medicine, United States;1. Department of Communication (0503), University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0503, USA;2. Department of Anthropology, University of California, Berkeley, USA;1. Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, New York;2. Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, Michigan;3. National Center for Organization Development, Veterans Health Administration, Cincinnati, Ohio;4. Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina;5. Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California;1. Department of Pediatrics, SUNY Upstate Medical University, Syracuse, NY 13210, United States;2. Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, United States;3. Department of Otolaryngology and Communication Sciences, SUNY Upstate Medical University, Syracuse, NY 13210, United States |
| |
| Abstract: | BackgroundSince its FDA approval in 2006, the Human papillomavirus (HPV) vaccine has been politically-charged, given its association with sexual health among young women and its history of controversial, and largely unsuccessful, legislative mandates. The extent to which perceived politicization is related to public support for the vaccine’s use, however, is not clear. We sought to examine the relationship between public perceptions of politicization of the HPV vaccine and public support for HPV vaccine policies.MethodsWe fielded a survey from May-June 2016 using a nationally representative sample of U.S. adults (18–59 years). Among respondents aware of the HPV vaccine (n = 290), we predict support for HPV vaccine policies based on respondents’ perceptions of three characteristics of the vaccine’s portrayal in public discourse: degree of controversy, certainty of the scientific evidence supporting the vaccine’s use, and frequency with which the vaccine appears in political discussion.ResultsRespondents who perceived greater certainty about the scientific evidence for the HPV vaccine were more supportive of HPV vaccine policies (p < 0.0001) than respondents who perceived the scientific evidence to be uncertain, after adjusting for respondents’ characteristics, including demographics and partisanship.ConclusionsPublic perceptions of the HPV vaccine’s politicization, particularly the portrayal of scientific evidence, are associated with receptivity to legislative mandates.Policy implicationsHow the certainty of a body of evidence gets communicated to the public may influence the policy process for a critical cancer prevention intervention. |
| |
| Keywords: | HPV vaccine Legislation Public health Health policy Politics Cancer prevention |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
